Ivan Horbachevsky Ternopil National Medical University or simply Ternopil National Medical University is a government university run by the Ministry of Health as well as a medical university located in the city of Ternopil in Ukraine.

During the past decade, Municipal Non-commercial Enterprise Ternopil University Hospital of Ternopil Regional Council conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 15 clinical trials were completed, i.e. on average, 39.5% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 14 clinical trials were completed. i.e. 82.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Municipal Non-commercial Enterprise Ternopil University Hospital of Ternopil Regional Council" #1 sponsor was "Janssen Research & Development, LLC" with 14 trials, followed by "Celgene" with 6 trials sponsored, "Actelion" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Eli Lilly and Company" with 3 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Municipal Non-commercial Enterprise Ternopil University Hospital of Ternopil Regional Council" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator, "H. Lundbeck A/S" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Municipal Non-commercial Enterprise Ternopil University Hospital of Ternopil Regional Council" are "Arthritis, Psoriatic" (7 trials), "Crohn Disease" (6 trials), "Ulcerative Colitis" (6 trials), "Crohn's Disease" (3 trials) and "Atopic Dermatitis" (2 trials). Many other conditions were trialed in "Municipal Non-commercial Enterprise Ternopil University Hospital of Ternopil Regional Council" in a lesser frequency.

Most popular intervention types in "Municipal Non-commercial Enterprise Ternopil University Hospital of Ternopil Regional Council" are "Drug" (36 trials), "Other" (7 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Guselkumab" (7 trials), "Filgotinib" (3 trials), "GED-0301" (3 trials) and "Ozanimod" (3 trials). Other intervention names were less common.

The vast majority of trials in "Municipal Non-commercial Enterprise Ternopil University Hospital of Ternopil Regional Council" are 38 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Municipal Non-commercial Enterprise Ternopil University Hospital of Ternopil Regional Council". undefined are not yet recruiting, 11 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Municipal Non-commercial Enterprise Ternopil University Hospital of Ternopil Regional Council, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Municipal Non-commercial Enterprise Ternopil University Hospital of Ternopil Regional Council, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".